People news: Par Pharmaceutical

Share this article:
Par Pharmaceutical Companies said John MacPhee had resigned as president of Strativa Pharmaceuticals and EVP Par Pharmaceutical “to pursue other interests” after six years with the company. Day-to-day oversight of Strativa, the company's proprietary products division, will be assumed by Par chairman, president and CEO Patrick LePore on an interim basis. Woodcliff Lake, NJ-based Par's focus is on marketing higher-barrier-to-entry generics and niche, innovative branded drugs.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions